Ramina Fazeli: Highlighting the Emerging Role of Neutrophil Extracellular Traps in Ovarian Cancer
Ramina Fazeli, Medical Doctor at Alborz University of Medical sciences, shared a post on LinkedIn about a recent article she and her collegues co-authored, published in adding:
“This review highlights the emerging role of neutrophil extracellular traps (NETs) in ovarian cancer progression, tumor microenvironment remodeling, immune evasion, angiogenesis, and therapeutic resistance.
We also discussed the molecular pathways involved in NETosis and explored the potential of NET-targeted therapies as promising strategies to improve treatment response and patient outcomes in ovarian cancer.
I am grateful to all co-authors and collaborators for their valuable contributions to this work.
I hope this article adds to the growing understanding of the complex interactions between inflammation, immunity, and cancer biology.”
Title: The neutrophil–NET Axis in ovarian cancer: Drivers of tumor microenvironment remodeling and therapeutic resistance
Authors: Hoda Zendehdel, Mahsa Esgandari, Paria Panahinia, Ramina Fazeli, Atoosa Etezadi, Sania Rahimi
Stay updated on all scientific advances with Hemostasis Today.
-
May 24, 2026, 16:12William Wallace: Normal B12 Levels May Still Cause Brain Damage and Cognitive Decline
-
May 24, 2026, 15:54Marc Carrier: Ottawa Race Weekend Raised Over 7,000 USD for Thrombosis Canada
-
May 24, 2026, 15:44Janak Sadhu: Building a Stroke-Free Mehsana Through Community Awareness and Healthcare Collaboration
-
May 24, 2026, 15:33Mohammed Zubair: AI-Driven Innovation in Stroke Diagnosis and Medical Imaging
-
May 24, 2026, 14:26Salome Mekhuzla: World Health Assembly Adopts Historic Global Resolution for Hemophilia and Bleeding Disorders
-
May 24, 2026, 13:10Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View